← Back to Search

Genetic Counseling for Thyroid Cancer

N/A

Recruiting

Led By Junne Kamihara, MD, PhD

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Pediatric patient with current or previous known or suspected thyroid cancer or nodule(s)

Adult patient with current or previous known or suspected thyroid cancer or nodule(s) from a family with a high suspicion of hereditary cancer

Must not have

Individuals who are unable to give informed consent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at families with a history of thyroid cancer to try and understand what causes the cancer and how it can be prevented.

Who is the study for?

This trial is for children and adults with current or past thyroid cancer or nodules, especially if there's a strong suspicion that the condition might be inherited. It includes those from families where multiple members had thyroid cancer, associated genetic syndromes, or various cancers at a young age.

What is being tested?

The study involves collecting family and medical history information along with blood or saliva samples to understand genetic factors contributing to thyroid cancer risk. Participants may also be referred to a genetic counselor if needed.

What are the potential side effects?

There are no direct side effects from participating in this study as it does not involve drug treatments. However, providing blood samples can sometimes result in bruising, bleeding, or infection at the puncture site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a child with current or past thyroid cancer or nodules.

Select...

I have or might have thyroid cancer, or nodules, with a family history of cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am able to understand and agree to the study's procedures and risks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Higher Suspected Familial PredispositionExperimental Treatment1 Intervention

Higher Suspected Familial Predisposition Screening and Enrollment: Consent, Family HX, Medical HX, Blood/Saliva which will categorize by suspected hereditary predisposition: Based on family and medical history. - Specimen Testing and Analysis •Referral to Genetic Counselor, if indicated

Group II: Lower Suspected Familial PredispositionActive Control1 Intervention

Lower Suspected Familial Predisposition Screening and Enrollment: Consent, Family HX, Medical HX, Blood/Saliva which will categorize by suspected hereditary predisposition: Based on family and medical history. - Sample stored in Biorepository

0 / 3Eligibility criteria met